Foment Bio, Inc.
New Form D on file · 2025-03-21 · the record
Before you sell to, join or invest in Foment Bio, Inc.
MentionFox check on Foment Bio, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/foment-bio-inc-form-d-25000001
Check Foment Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Foment Bio, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Foment Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-21.
Foment Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 21, 2025. The filing reports $543K sold. Its industry group is Pharmaceuticals. It names Ben Chlebina (Executive Officer), Marc Penn (Director) (SEC Form D, March 21, 2025).
Is this your company?
Sell to companies like Foment Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Foment Bio, Inc.
Free to see. No signup.
More on the people and the money behind Foment Bio, Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Foment Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Foment Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Foment Bio, Inc. →Get the full cited report on Foment Bio, Inc.
What the filing shows about Foment Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Foment Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Foment Bio, Inc.'s address as 148 Wick Willow Rd, Montgomery, TX 77356.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Foment Bio, Inc. is a registered filer with the SEC (CIK 2062787) and has filed since 2025-03-21. 1 filing is on record, the latest on 2025-03-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Foment Bio, Inc.'s Form D of 2025-03-21 names Ben Chlebina and Marc Penn as its officers, directors or promoters.
Its new offerings report $543K sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Ben Chlebina is named as Executive Officer on the Form D that Foment Bio, Inc. filed with the SEC on 21 March 2025, one of 2 people that filing names.
Marc Penn is named as Director on the Form D that Foment Bio, Inc. filed with the SEC on 21 March 2025, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2025-03-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Foment Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Foment Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Foment Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Foment Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Foment Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Foment Bio, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/foment-bio-inc-form-d-25000001